DNA methylation analysis of NOTCH1 variants reveals the first episignature for non-syndromic congenital heart defects

We identified that NOTCH1-haploinsufficiency variants represented the most common monogenic cause in our cohort and accounted for an estimated 1 % of CHD cases. Furthermore, we conclude that methylation profiling can contribute to (NOTCH1) variant interpretation and improve the diagnostic management of CHD patients. Lastly, we established a NOTCH1-specific episignature, which represents the first non-syndromic signature, significantly extending the scope of patients that can benefit from methylation analysis.

Authors

Institutions

Publication Details

Journal
Genome Medicine
Published
2026-01-07
DOI
https://doi.org/10.1186/s13073-025-01587-6
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DNA methylation analysis of NOTCH1 variants reveals the first episignature for non-syndromic congenital heart defects

David S. Winlaw, Marcel M. A. M. Mannens, Brigitte Stiller, Niels Vos et al.
Genome Medicine
Genomics and Rare Diseases
article

DNA methylation analysis of NOTCH1 variants reveals the first episignature for non-syndromic congenital heart defects

David S. Winlaw, Marcel M. A. M. Mannens, Brigitte Stiller, Niels Vos, Robert B. Russell, Thomas Pickardt, Gregor Dombrowsky, Peter Henneman, Liselot van der Laan, Alex V. Postma, Seema R. Mital, Robert Lesurf, Sabine Klaassen, Anselm Uebing, Anna Wilsdon, Michaël Levy, Ulrike Bauer, Jiao Wang, Felix Berger, Anjali Jain, Hans-Heiner Kramer, Hashim Abdul-Khaliq, Ingo Dähnert, Siobhan Loughna, Bekim Sadikovic, Connie R. Bezzina, Frances Bu’Lock, Sven Dittrich, Enrique Audain, J. David Brook, Marc-Phillip Hitz, Mary Ann Thomas, Ananília Silva, Jeroen Breckpot, Almuth Caliebe
article en

Abstract

We identified that NOTCH1-haploinsufficiency variants represented the most common monogenic cause in our cohort and accounted for an estimated 1 % of CHD cases. Furthermore, we conclude that methylation profiling can contribute to (NOTCH1) variant interpretation and improve the diagnostic management of CHD patients. Lastly, we established a NOTCH1-specific episignature, which represents the first non-syndromic signature, significantly extending the scope of patients that can benefit from methylation analysis.

Genome MedicineVol. 18(1)
Western University (CA), Carl von Ossietzky Universität Oldenburg (DE), University of Nottingham (GB), University of Calgary (CA), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), University of Toronto (CA), Max Delbrück Center (DE), Heidelberg University (DE), London Health Sciences Centre (CA), Hospital for Sick Children (CA), Glenfield Hospital (GB), Universitätsklinikum Erlangen (DE), Deutsches Herzzentrum der Charité (DE), University Hospital Schleswig-Holstein (DE), Leipzig Heart Institute (DE), Lurie Children's Hospital (US), German Centre for Cardiovascular Research (DE), Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE), SickKids Foundation (CA), Deutsches Herzzentrum München (DE), Amsterdam University Medical Centers (NL), Charité - Universitätsmedizin Berlin (DE), Heidelberg University (US), University of Amsterdam (NL), Saarland University (DE), University of Lübeck (DE), KU Leuven (BE)
Wellcome Trust, Deutsches Zentrum für Herz-Kreislaufforschung, Bundesministerium für Bildung und Forschung, KU Leuven, Radboud Universitair Medisch Centrum, Alliance de recherche numérique du Canada
Openalex Percentile: Top 96%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.